FDA Adverse Event Injury Summary report: N

COREVALVE TRANSCATHETER AORTIC VALVE

MDR report key: 7015250 · Received November 9, 2017

Report

Report Number
2025587-2017-02068
Event Type
Injury
Date Received
November 9, 2017
Date of Event
July 29, 2015
Report Date
November 9, 2017
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: ELVIN KESIMCI. IMPACT OF DIFFERENT ANESTHETIC MANAGEMENTS IN OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION: THE FIRST TURKISH EXPERIENCE. TURK J MED SCI. 2016; 46: 742-748. DOI: 10.3906/SAG-1503-74 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING THE IMPACT OF DIFFERENT ANESTHETIC MANAGEMENTS IN OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION. ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN JULY 2011 AND JANUARY 2014. THE STUDY POPULATION INCLUDED 151 PATIENTS (PREDOMINANTLY FEMALE; MEAN AGE 76 YEARS), 54 OF WHICH WERE IMPLANTED WITH MEDTRONIC COREVALVE(R) REVALVING SYSTEM (CRS) (SERIAL NUMBERS NOT PROVIDED). AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: HEMODYNAMIC INSTABILITY, VASCULAR COMPLICATIONS, RHYTHM DISTURBANCES, AND PERMANENT PACEMAKER IMPLANTATION. MULTIPLE MANUFACTURERS WERE NOTED IN THE LITERATURE; BASED ON THE AVAILABLE INFORMATION A DIRECT CORRELATION COULD NOT BE MADE BETWEEN THE OBSERVED ADVERSE EVENTS AND MEDTRONIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
793639 COREVALVE TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION CRS

Patients

Seq Age Sex Outcome Treatment
1 76 YR Required Intervention